Shares of Merck KGaA (OTCMKTS:MKGAF - Get Free Report) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $146.66 and traded as low as $143.70. Merck KGaA shares last traded at $143.70, with a volume of 7 shares changing hands.
Merck KGaA Stock Performance
The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market cap of $19.28 billion, a price-to-earnings ratio of 22.77 and a beta of 0.96. The firm's 50 day moving average is $146.46 and its 200-day moving average is $157.92.
About Merck KGaA
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
